Key messages

  • The inaugural Victorian Medical Research Acceleration Fund makes available two tiers of funding up to $100,000 and $500,000. 
  • The aim of the fund is to support the translation of early stage health and medical research into health and economic outcomes. 
  • Health services, industry, medical research institutes and education institutes can apply for funding. 

In 2017 the Victorian Medical Research Acceleration Fund is investing $3 million into 13 projects that help transform health and medical research into everyday clinical practice and patient care.

The successful recipients were selected following a highly competitive process, overseen by leading scientists, academics, clinicians and industry experts. By harnessing the power of new breakthroughs, this research will deliver better health outcomes for patients and save lives, in Victoria and across the world.

Projects include the development of new technologies to treat severe asthma, a ‘virtual hospital’ providing greater accessibility to treatment and support for patients with chronic disease, a new treatment for ovarian cancer and for weight loss in patients with cancer.

These innovative projects will also leverage funding from philanthropic, industry and international sources, meaning a further $7 million will be invested into Victoria’s medical research sector.

The investment will provide new business opportunities, create jobs and encourage economic growth across Victoria. And it will enhance Victoria’s reputation as a world leader in health and medical research.

Round 2 funding details will be announced in 2018.

2017 (Round 1) recipients 

Tier 1 awardees received up to $100,000 to support early stage research including discovery and clinical research, health practice, or an idea or innovation to attract investment. The successful applications are:

  • Vivid White Pty Ltd
  • Monash University
  • Deakin University
  • Burnet Institute
  • Monash University
  • Austin Health
  • Baker Heart and Diabetes Institute
  • Monash University.

Tier 2 awardees received up to $500,000 to support a small number of research proposals to fast-track translation into health and economic outcomes. Matching funding was required to demonstrate capacity to collaborate and undertake research with a clear pathway to translation. The successful applications are:

  • University of Melbourne
  • Monash University
  • InCarda Therapeutics Australia Pty Ltd
  • Cartherics Pty Ltd
  • La Trobe University.

Read the project summaries from the thirteen successful Round 1 applications.

About the fund

The Victorian Medical Research Acceleration Fund aims to support those in the early stages of health and medical research to translate their work into health and economic outcomes. 

The competitive program leverages funding from philanthropic, industry and international sources. It's designed to capitalise on Victoria’s comparative advantages in medical research, increase the efficiency of the Victorian health system and further enhance the Victorian economy’s investment attractiveness. 

Who can apply

Applications will be accepted from collaborations or partnerships between:

  • health services
  • industry
  • medical research institutes
  • education institutes.

Available funds

The Victorian Medical Research Acceleration Fund will provide $3 million per annum to help address current market gaps and deliver rewards for research. Funding is divided into two tiers.

Tier 1 funding is for proposals up to $100k. It supports early stage innovations including discovery research, clinical research and health practice, or an idea or innovation to attract peer review funding or investment by industry.

Tier 2 funding is for proposals up to $500k. It supports a small number of research proposals to ‘fast track’ translation into health and economic outcomes. Matching funding will be required to demonstrate capacity to collaborate and undertake research that has a clear pathway to translation.